US Patent Issued to Abbott Diabetes Care on Sept. 23 for "Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems" (California Inventor)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,589, issued on Sept. 23, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems" was invented by Jean-Pierre Cole (Tracy, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, devices, systems, and kits are provided that buffer the time spaced glucose signals in a memory, and when a request for real time glucose level information is detected, transmit the buffered glucose signals and real time monitored glucose level information to a remotely located device, process a subset of the received gl...